Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | LIC MF BSE Sensex Index Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹103.71 |
| 12 Apr 2015 | ₹144.68 |
| 31 May 2016 | ₹133.89 |
| 19 Jul 2017 | ₹161.08 |
| 07 Sep 2018 | ₹193.30 |
| 27 Oct 2019 | ₹198.12 |
| 15 Dec 2020 | ₹236.05 |
| 03 Feb 2022 | ₹301.73 |
| 25 Mar 2023 | ₹297.94 |
| 12 May 2024 | ₹380.47 |
| 01 Jul 2025 | ₹442.83 |
| 20 Aug 2026 | ₹412.65 |
| Metric | LIC · Direct · IDCW NAV ₹52.46 Very High risk ★★☆☆☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -4.91% | +5.06% | |
| +6.76% | +7.78% | |
| +7.82% | +8.94% | |
| +11.28% | +10.39% | |
| +10.96% | +7.54% | |
| +5.69% | — | |
| +12.31% | +8.12% | |
| +12.83% | +12.83% | |
| +12.43% | +11.97% | |
| Risk | ||
| 13.18% | 13.54% | |
| 0.02 | 0.16 | |
| 0.03 | 0.22 | |
| -37.53% | -15.77% | |
| Nifty 50 | — | |
| -1.03% | +0.53% | |
| 0.98 | 1.00 | |
| 97.7% | 102.2% | |
| 104.0% | 98.0% | |
| 0.66% | 0.34% | |
| ₹90.05Cr | ₹191.88Cr | |
| 0.25% | — | |
| None | — | |
| ₹200 | — | |
| ₹5.00K | — | |
| 27% | 38% | |
| Sumit Bhatnagar · 2.9y | — | |
| 02 Jan 2013 | — | |
| 30 | — | |
| 64.0% | — | |
| 0.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.